EYPT
EyePoint·NASDAQ
--
--(--)
--
--(--)
EYPT Profile
Eyepoint, Inc.
A pharmaceutical company that focused on ophthalmic treatments
480 Pleasant Street, Watertown, MA 02472
--
EyePoint, Inc., incorporated in Delaware on March 19, 2008, is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapies to help improve the lives of patients with severe retinal diseases. The Company adopts its proprietary biodegradable Durasert E ™Technology for continuous intraocular drug delivery, thus solving the problem caused by frequent intravitreal injections. Its main product candidate DURAVYU ™It is an investigational therapy for the treatment of vascular endothelial growth factor-mediated retinal diseases.
